image 5
image 6
image 4
image 7
image 3
image 8
image 1
image 2

The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research"

Professor Karl Skorecki

Ruth Alon of Pitango appointed to the Board of Directors of BioRap

1 January, 2004

Ruth Alon, co-director of the “Pitango” VC fund and responsible for the life sciences field, was appointed to the Board of Directors of BioRap Technologies Ltd., the commercialization subsidiary of the Rappaport Institute. Ms. Alon is responsible for Pitango’s investment activities in the medical and biotechnology spheres and is considered one of the key and most active figures in the life sciences industry in Israel. Ms. Alon is a board member of numerous companies, among them Colbar, BrainsGate, Bioline RX, BioControl, Transpharma, Proneuron, Optonol, Disc-O-Tech.

Copyright � 2014 BioRap Technologies LTD. All Rights Reserved. Created by Catom web design